1. Market Research
  2. > Consumer Goods Market Trends
Aortic Valve Market by Product, by Procedure, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

Aortic Valve Market by Product, by Procedure, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

  • December 2018
  • 254 pages
  • ID: 5479790
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

Aortic Valve Market by Product (Valve Type [Tissue/Biological, Mechanical], Suture Type [Sutured, Sutureless]), by Procedure (Minimally Invasive Surgery [Transfemoral, Transapical], Open Surgery [Tissue/Biological, Mechanical]), by End User (Hospitals, Ambulatory Surgery Centers), by Geography (Germany, France, U.K., Italy, Spain, U.S., Canada, Japan, China, Taiwan, Brazil, Mexico, South Africa) - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

Aortic valve market is expected to reach $9,859.8 million by 2023, owing to rising prevalence of valvular heart diseases (VHDs), increasing preference for minimally invasive surgeries (MISs), initiatives for creating awareness about valve replacement, and favorable reimbursement scenario related to aortic valves.

Based on product, the market is bifurcated in terms of valve type and suture type. On the basis of valve type, the aortic valve market has been categorized into tissue/biological and mechanical valves. Tissue/biological aortic valves held 88.1% share in the market in 2017. This can be mainly attributed to advancements in technology and rising adoption of tissue/biological valves, globally.

Based on suture type, the aortic valve market for sutureless valves is projected to witness significant growth during the forecast period, with 22.9% CAGR in terms of value. This can be mainly ascribed to the advantages of these valves over sutured valves, such as reduction in the duration of cross-clamp and cardiopulmonary bypass (CPB) procedures. It is further predicted that over 30 thousand units of sutureless aortic valves would be sold by 2023, as compared to over 8 thousand valves sold in 2017.

Aortic valves can either be replaced through open surgeries or MISs. The MISs for aortic valve implantation held larger share in the aortic valve market in 2017, with a revenue contribution of $3,519.8 million. This can be attributed to the fact that MISs, unlike open surgeries, involve a smaller number of incisions to reduce trauma.

Hospitals and ambulatory surgery centers (ASCs) are the prime end users in the aortic valve industry, where hospitals constitute a larger end-user base for aortic valves and are expected to generate revenue of $8,106.4 million in the market by 2023. This can be attributed to the highly advanced healthcare facilities and optimized patient care provided in hospitals.

In comparison to global market growth, the European market is expected to observe the fastest growth during the forecast period, with 11.6% CAGR, owing to the increasing prevalence of cardiovascular diseases (CVDs), growing acceptance for technologically advanced products, and improving healthcare infrastructure in the region. The European aortic valve market is driven by factors, such as significant prevalence of aortic stenosis in the European countries, availability of various treatment options including transcatheter aortic valve replacement (TAVR), and rising initiatives for creating awareness about valve replacement surgeries in the region.

Furthermore, lack of awareness on CVDs, particularly aortic stenosis, leads to late diagnosis and health deterioration in patients. However, initiatives are being taken in the European region to create awareness among people about CVDs and their treatment options. The European Heart Valve Disease Awareness Day, aims at improving diagnosis, treatment, and management of heart valve diseases in Europe, was held for the first time in September 2018.

Companies are attaining a number of approvals for their products, in order to enter into the aortic valve market. For instance, in June 2018, LivaNova PLC received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW), for its Perceval sutureless aortic heart valve, which is used for the treatment of aortic valve diseases. Before that, in March 2018, LivaNova PLC received Conformité Européene (CE) approval for its Bicarbon aortic valves for use with a low-dose anticoagulant therapy. This expanded indication of the company’s Bicarbon family of mechanical valves was based on the evidence and results collected from the LOWERING-IT trial, where patients saw 60% reduction in the risk of bleeding.

Some of the other key players in the aortic valve industry are Boston Scientific Corporation, Edwards Lifesciences Corporation, CryoLife Inc., Medtronic plc, Abbott Laboratories, Venus Medtech (Hangzhou) Inc., and LifeNet Health.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Surgical Sutures - Medical Devices Pipeline Assessment, 2019

Surgical Sutures - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • December 2019

Surgical Sutures - Medical Devices Pipeline Assessment, 2019Summary Medical Devices sector report, “Surgical Sutures - Medical Devices Pipeline Assessment, 2019" provides an overview of Surgical Sutures ...

Global Surgical Sutures Market 2020-2030

Global Surgical Sutures Market 2020-2030

  • $ 4374
  • October 2019

Absorbable Sutures, Non-Absorbable Sutures, Automated Suturing Devices, General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gyneoclogical Surgery, Ophthalmic Surgery, Facial, Cosmetic & Plastic ...

Global Surgical Sutures Industry

Global Surgical Sutures Industry

  • $ 5450
  • October 2019

Surgical Sutures market worldwide is projected to grow by US$1.6 Billion, driven by a compounded growth of 5.1%. Automated Suturing Device, one of the segments analyzed and sized in this study, displays ...


ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on